A Dissertation on
Clinical, Bacteriological and Radiological Study of Community Acquired Pneumonia
Dissertation Submitted to THE TAMILNADU Dr.M.G.R. MEDICAL UNIVERSITY CHENNAI - 600 032
With partial fulfillment of the regulations for the award of the degree of
M.D. GENERAL MEDICINE BRANCH-I
COIMBATORE MEDICAL COLLEGE, COIMBATORE MAY 2018
CERTIFICATE
Certified that this is the bonafide dissertation done by
Dr. REKA.R and submitted in partial fulfillment of the requirements for the Degree of M.D.,General Medicine , Branch I of The Tamilnadu Dr.
M.G.R. Medical University, Chennai.
Date: Guide, Professor & Head Department of Medicine
Date: Dean Coimbatore Medical College Coimbatore
DECLARATION
I solemnly declare that the dissertation titled “Clinical,
Bacteriological and Radiological Study of Community Acquired
Pneumonia ” was done by me from JULY 2016 to JUNE 2017 under the guidance and supervision of Professor Dr. KUMAR NATARAJAN
M.D (General Medicine)
This dissertation is submitted to The Tamilnadu
Dr.M.G.R.Medical University towards the partial fulfillment of the requirement for the award of MD Degree in General Medicine (Branch I).
Place: Coimbatore Dr. REKA .R Date:
ACKNOWLEDGEMENT I wish to express my sincere thanks to our respected Dean Dr. B.ASHOKAN M.S.,Mch for having allowed me to conduct this study in our hospital.
I express my heartfelt thanks and deep gratitude to the Head of the Department of Medicine Prof. Dr.KUMAR NATARAJAN M.D . (General Medicine) for his generous help and guidance in the course of the study.
I sincerely thank all professors and Asst. Professors- Dr.P.S.MANSHUR M.D, (General Medicine) DR.V.UVARAJ MURUGANANDAM M.D for their guidance and kind help.
My sincere thanks to Dr. S.KEERTHIVASAN M.D., CHEST MEDICINE, Chief, Department of Thoracic Medicine, for his help.
My sincere thanks to all my friends and post-graduate colleagues for their whole hearted support and companionship during my studies.
I thank all my PATIENTS , who formed the backbone of this study without whom this study would not have been possible.
Lastly, I am ever grateful to the ALMIGHTY GOD for always showering His blessings on me and my family.
DATE: Dr. REKA .R
CERTIFICATE – II
This is to certify that this dissertation work titled Clinical,
Bacteriological and Radiological Study of Community Acquired
Pneumonia of the candidate Dr. REKA .R with registration Number
201511311 for the award of M.D in the branch of General Medicine I personally verified the urkund.com website for the purpose of plagiarism
Check. I found that the uploaded thesis file contains from introduction to conclusion pages and result shows 0% (zero percentage) percentage of plagiarism in the dissertation.
Guide & Supervisor sign with Seal.
LIST OF ABBREVIATIONS USED
CAP - COMMUNITY ACQUIRED PNEUMONIA
HIV - HUMAN IMMUNO DEFICIENCY VIRUS
COPD - CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CNS - CENTRAL NERVOUS SYSTEM
DNA - DEOXYRIBONUCLEIC ACID
RNA - RIBONUCLEIC ACID
PCR - POLYMERASE CHAIN REACTION
ICU - INTENSIVE CARE UNIT
WBC - WHITE BLOOD COUNT
BUN - BLOOD UREA NITROGEN
PSI - PNEUMONIA SEVERITY INDEX
DIC - DISSEMINATED INTRAVASCULAR COAGULATION
MDR - MULTI DRUG RESISTANCE
ACIP - ADVISORY COMMITTEE ON IMMUNIZATION
PRACTICES
CA MRSA - COMMUNITY ASSOCIATED METHICILLIN-
RESISTANT STAPHYLOCOCCUS AUREUS
HCAP - HEALTHCARE-ASSOCIATED PNEUMONIA
CMCH - COIMBATORE MEDICAL COLLEGE HOSPITAL
CONTENTS
S/No Title Page No 1 INTRODUCTION 1
2 AIM AND OBJECTIVES 2
3 REVIEW OF LITERATURE 3-43
4 MATERIALS AND METHODS 44-46
5 RESULTS 47-102
6 DISCUSSION 103-108
7 CONCLUSION 109
8 BIBLIOGRAPHY 110-117
9 ANNEXURES 118-126
• A 1 – PROFORMA
• A2 – MASTER CHART
• A3 – CONSENT FORM
LIST OF TABLES
S/No TABLE PAGE NO 1 Causes of CAP 5
2 Pathogens commonly encountered in CAP 6-8
3 Antibiotic Treatment of CAP 40
4 Age Distribution in decades, in the Study Population 47
5 Age Distribution in the Study Population 48
6 Sex Distribution in the Study Population. 49
7 Age Vs Sex 50
8 Cough Manifestation in The Study Population 51
9 Cough Vs Age 52
10 Fever Manifestation in the Study Population 53
11 Age Vs Fever 54
12 Expectoration in the Study Population 55
13 Age Vs Expectoration 56
14 Pleuritic Chest in the Study Population 57
15 Age Vs Pleuritic Chest Pain 58
16 Dyspnoea in the Study Population 59
17 Age Vs Dyspnoea 60
18 Hemoptysis in the Study Population 61
19 Age Vs Hemoptysis 62
20 Crepitation in the Study Population 63
21 Age Vs Crepitation 64
22 Cyanosis in the Study Population 65
23 Age Vs Cyanosis 66
24 Bronchial Breath Sounds in the Study Population 67
25 Age Vs Bronchial Breath Sounds 68
26 Altered Sensorium in the Study Population 69
27 Age Vs Altered Sensorium 70
28 Pleural Effusion in the Study Population 71
29 Age Vs Pleural Effusion 72
30 Smokers in the Study Population 73
31 Age Vs Smokers 74
32 Alcoholics in the Study Population 75
33 Age Vs Alcoholics 76
34 Diabetes Mellitus Patients in the Study Population 77
35 Age Vs Diabetes Mellitus 78
36 Hypertension Patients in the Study Population 79
37 Age Vs Hypertension 80
38 COPD Patients in the Study Population 81
39 Age Vs COPD 82
40 Sputum Culture results in the Study Population 83
41 Gram Staining results in the Study Population 84
42 Age Vs Gram Staining 85
43 Culture Organisms in the Study Population 86
44 Age Vs Culture Organism 87
45 Blood Culture Growth Results in the Study Population 88
46 Age Vs Blood Culture Growth 89
47 Pleural Fluid Growth Results in the Study Population 90
48 Age Vs Pleural Fluid Growth 91
49 Consolidation in X Ray Results in the Study 92 Population 50 Age Vs Consolidation in X Ray 93
51 Consolidation in CT Chest Results in the Study 94 Population 52 Age Vs Consolidation in CT Chest 95
53 Signs And Symptoms in the Study Population 96
54 Co Morbidities in the Study Population 97
55 Culture Specimens in the Study Population 98
56 Correlation between Gram Negative Organism and 99 factors like smoking and COPD 57 Age Vs Duration of Disease 100
58 Disease Outcome in the Study Population 101
59 Age Vs Disease Outcome 102
LIST OF CHARTS
S/No CHARTS PAGE NO 1 Age Distribution in decades, in the Study Population 47
2 Age Distribution in the Study Population 48
3 Sex Distribution in the Study Population 49
4 Age Vs Sex 50
5 Cough Manifestation in The Study Population 51
6 Cough Vs Age 52
7 Fever Manifestation in the Study Population 53
8 Age Vs Fever 54
9 Expectoration in the Study Population 55
10 Age Vs Expectoration 56
11 Pleuritic Chest in the Study Population 57
12 Age Vs Pleuritic Chest Pain 58
13 Dyspnoea in the Study Population 59
14 Age Vs Dyspnoea 60
15 Hemoptysis in the Study Population 61
16 Age Vs Hemoptysis 62
17 Crepitation in the Study Population 63
18 Age Vs Crepitation 64
19 Cyanosis in the Study Population 65
20 Age Vs Cyanosis 66
21 Bronchial Breath Sounds in the Study Population 67
22 Age Vs Bronchial Breath Sounds 68
23 Altered Sensorium in the Study Population 69
24 Age Vs Altered Sensorium 70
25 Pleural Effusion in the Study Population 71
26 Age Vs Pleural Effusion 72
27 Smokers in the Study Population 73
28 Age Vs Smokers 74
29 Alcoholics in the Study Population 75
30 Age Vs Alcoholics 76
31 Diabetes Mellitus Patients in the Study Population 77
32 Age Vs Diabetes Mellitus 78
33 Hypertension Patients in the Study Population 79
34 Age Vs Hypertension 80
35 COPD Patients in the Study Population 81
36 Age Vs COPD 82
37 Sputum Culture results in the Study Population 83
38 Gram Staining results in the Study Population 84
39 Age Vs Gram Staining 85
40 Culture Organisms in the Study Population 86
41 Age Vs Culture Organism 87
42 Blood Culture Growth Results in the Study Population 88
43 Age Vs Blood Culture Growth 89
44 Pleural Fluid Growth Results in the Study Population 90
45 Age Vs Pleural Fluid Growth 91
46 Consolidation in X Ray Results in the Study 92 Population 47 Age Vs Consolidation in X Ray 93
48 Consolidation in CT Chest Results in the Study 94 population
49 Age Vs Consolidation in CT Chest 95
50 Signs And Symptoms in the Study Population 96
51 Co Morbidities in the Study Population 97
52 Culture Specimens in the Study Population 98
53 Correlation between Gram Negative Organism and 99 factors like smoking and COPD 54 Mean Duration of Disease 100
55 Disease Outcome in the Study Population 101
56 Age Vs Disease Outcome 102
LIST OF FIGURES
S/No FIGURES PAGE NO 1. X Ray Chest, Right Lobe Pneumonia 27
2. CT chest, Lobar Pneumonia. 27
3. Gram Staining, Gram Positive diplococci in 31 sputum gram stain
INTRODUCTION
Pneumonia is major cause of mortality and morbidity in both developing countries and developed countries. It is next to diarrhea among all acute infectious disease in mortality. It affects all age groups. Pneumonia is the major cause of death in children under five years and extremes of age. Due to over usage and misusage of oral and intra venous antibiotics, patients are infected with multidrug resistant pathogens. This can lead to healthcare associated pneumonia.
Due to lack of knowledge, lack of facilities, pneumonia most often misdiagnosed, under estimated and mistreated. One other reason for poor outcome of patients is, failure to assess the severity of the disease and to treat patient as outpatient or in hospital setup or in intensive care unit. Pneumonia is more common in immune compromised like
Diabetes, HIV and patient with chronic lung disease.
AIM AND OBJECTIVES
The study focuses on Clinical, Radiological and Bacteriological aspects of patients admitted in CMCH with Pneumonia.
OBJECTIVES:
The objectives of the study are as follows,
• To know the prevalence of causative microorganism of
COMMUNITY ACQUIRED PNEUMONIA in
Coimbatore region.
• Clinical presentation of patients.
• Radiological profile of the above patients.
REVIEW OF THE LITERATURE
DEFINITION
Pneumonia is defined as infection of lung parenchyma, it may be due to infectious or non infectious.
EPIDEMIOLOGY
Pneumonia is sixth leading cause of death in United States. The death rate per 100,000 patients was 21.8. In 2009, according to the centers for disease control and prevention, 1.1 million people were hospitalized, which among more than 50,000 were died from pneumonia 1.
In spite of having total number of deaths due to lower respiratory tract infections available, there is no systemic study conducted on incidence of pneumonia in India. According to World Health Organization, in India mortality due to infectious disease is caused by lower respiratory tract infections is around 20%.
ETIOLOGY
Etiology of CAP may be infective or non infective causes 2.
I. Infective causes :
Bacteriological causes :
• Staphylococcal pneumonia • Pneumococcal pneumonia • Pseudomonas pneumonia • Klebsiella pneumonia • Haemophilus influenza pneumonia • Escherichia pneumonia • Chlamydia pneumonia • Morexella catarrhalis pneumonia • Mycoplasma pneumonia • Legionella pneumonia
Viral causes :
• Measles virus • Influenza, cytomegalo virus • Hanta virus • Respiratory synctial • Corona virus • Metapneumo virus
Other agents like coccidiodes, histoplasma, parasitic pneumonia and blastomycoces produces pneumonia.
2. Non infective
Non Infective causes like Radiation Pneumonia and lipid physical pneumonia 3.The most common causes of CAP depends on the situations where the infection occurs, as shown below 4,
Table : Causes of CAP
According to risk factor and epidemiologic condition, the pathogen aetiological agent may vary in CAP 5. Which are
Condition Pathogens commonly encountered Age more than 65years Streptococcus pneumonia Co morbidity like Staphylococcus aureus cardiovascular disease, Gram negative enteric bacilli COPD, diabetes mellitus, Streptococcus pneumoniae neurological disease , recent Haemophilus influnzae viral infection, chronic renal or liver failure Aspiration Oral anaerobes, Gram negative enteric bacilli Exposure to bird or bat Histoplasma capsulatum droppings Rabits exposure Francisella tularensis HIV infection (late) Streptococcus pneumonia M.tuberculosis Haemophilus influnzae Cryptococcus Pneumocystis jirovecii, Aspergillus Histoplasma, P.aeruginosa Atypical mycobacteria HIV infection (early) Streptococcus pneumonia M.tuberculosis Haemophilus influnzae Travel to or residence in Hanta virus southwestern united states Coccidiodes species Community where Influenza Staphylococcus aureus is active Streptococcus pneumoniae Haemophilus influnzae Influenza
Structural lung diseases like Staphylococcus aureus Bronchiectasis P.aeruginosa Burkholderia cepacia Endobronchial Obstruction Staphylococcus aureus Streptococcus pneumoniae Haemophilus influnzae Anaerobes Alcoholism Streptococcus pneumonia M.tuberculosis Acinetobacter species Klebsiella pneumonia Oral anaerobes Patients in Institutions Staphylococcus aureus Gram negative enteric bacilli Streptococcus pneumonia Anaerobic bacteria in elderly non ambulatory patients Smoking and/or COPD Streptococcus pneumoniae Haemophilus influnzae Legionella species P.aeruginosa Chlamydophilis pneumonia Moraxella catarrhalis Lung abscess Staphylococcus aureus M.tuberculosis Community acquired MRSA Atypical mycobacteria Endemic fungal Oral anaerobes Exposure to birds Chlamydophilia psittaci Avian influenza if poultry Exposure to parturient cats or Coxiella burnetti farm animals
Cruise or hotel stay in last 2 Legionella species weeks Travel to or residence in Severe acute respiratory syndrome south east and east asia Avian influenza Burkholderia pseudomallei Post tussivative vomiting or Bordetella pertussis whooping cough for 12 weeks Drug use as injection Staphylococcus aureus M.tuberculosis Streptococcus pneumonia Anaerobes Hospital Admission Gram negative enteric bacilli Within 3 to 4 weeks Streptococcus pneumonia Within one year Bioterrorism context Francisella tularensis, Yersinia pestis, Bacillus anthracis Treated with antibiotics like Resistant micro organisms penicillin and others Streptococcus pneumonia
Classification of Pneumonia:
Based on different studies, there are different types of classification as described below 6.
1. Anatomical classification :
b) Lobar pneumonia
c) Segmental Pneumonia
d) Sub segmental Pneumonia
2. Microbiologist’s classification
a) Bacterial
b) Bacteria like and Rickettsia like pneumonia
c) Viral
d) Fungal
e) Chemical Pneumonia
f) Parasitic Pneumonia
g) Physical pneumonia – ionizing pneumonia
3.Empiricist’s classification:
a) Hospital Acquired Pneumonia
b) Community Acquired Pneumonia
c) Immuno compromised pneumonia – AIDS related
4. Behaviorist’s classification:
a) Difficult pneumonia
b) Easy pneumonia
Causative organism based classification of pneumonia is more widely used when compared to anatomical based classification of pneumonia. There are some conditions when lesion in lung is diagnosed
as pneumonia but it fails to responds to treatment or rather it responds very late, then we name it as Non resolving Pneumonia 7.
Different physicians around the globe defined the non resolving pneumonia on basis of their own opinion, for example on basis of radiological infiltration not resolving, due time course of ten days with antibiotic therapy 8. There are also some conditions which become challenge to Physician, whether its delaying resolution due to host factor or diagnosis should be reconsidered, such as systemic immunological disease and congestive cardiac failure. Conditions like pulmonary embolism, pulmonary alveolar proteinosis, sarcoidosis, hypersensitive pneumonitis, systemic necrotizing vasculitis, Wegner’s granulomatosis and drug induced pneumonitis mimic like non- resolving pneumonia 9.
CAP defined as less than one week cough with or without expectoration, shortness of breath, pleuritic pain with at least one systemic feature such as chills and rigor, temperature more than 37.7 degree celcius or malaise and new focal chest sign like Bronchial breath sound or crackles and having no other explanation for the illness and patient is not in the hospital or other health care system and patient acquired infection in community setting 10 .
With available chest radiography in the hospital CAP is defined with above said symptom and chest X ray finding of patchy or lobar consolidation. Before diagnosing Pneumonia we should rule out some
conditions such as pulmonary edema, pulmonary infarction and acute respiratory distress syndrome 11 .
PATHOGENESIS:
Lung Anatomy:
Lung is a spongy structure which helps in purifying blood. There are three lobes in the right lung and two lobes in the left lung. Left lung is smaller than right lung. Lingual in the left lung is equivalent to middle lobe of the right lung. Right Main bronchus is more vertical than the left one. Because of this reason, aspirated materials such as vomit, blood or any other foreign body mostly enters right lung rather than the left lung 12 .
Both bronchi gives rise to bronchioles. Bronchioles are differentiated from bronchi by lack of submucosal glands and lack of cartilage.
Bronchioles gives rise to terminal bronchioles with diameter less than
2mm. distally to terminal bronchioles called as acinus, which are spherical approximately with 7mm diameter. Terminal bronchioles leadsto respiratory bronchioles which proceeds to alveolar ducts which branches to alveolar sacs 13 . Alveolar sacs are blind ends where gas exchange takes place.
Alveolar walls under microscopy consists of, from blood to air,
1. The interwining network of anastomosing capillaries by the
Capillary endothelium.
2. A basement membrane and surrounding interstitial tissue, which
separates epithelial cells of alveolar lining from endothelial cells,
3. Alveolar epithelium, two cell types, continuous in nature.
a. 95% of surface covered by type I pneumocytes, which are
flattened and plate like.
b. Type II pneumocytes, which are rounded.
There are two major reasons why type II pneumocytes are more important than type I pneumocytes 14 . They are
i. After type I cell destruction, Type II cells are those, which
helps in repair of destructed alveolar epithelium .
ii. Type II pneumocytes are sources of pulmonary surfactant, in
which under electron microscope contains osmophilic
lamellar bodies.
4. Alveolar Macrophages. Which may present free in alveolar spaces
or attached loosely to epithelial cells. Some Phagocytosed materials
and carbon particles are filled in alveolar macrophages.
The walls of alveoli are not solid in nature but contains many number of Pores of Kohn. Between adjacent alveoli, these pores allows bacteria and exudates 15 .
Our human body consist of numerous amount of microbial species from oral cavity to excretory passage. More than 200 microbial species are present in upper respiratory tract, with both aerobic and non aerobic microbes. Generally there is a belief that lower respiratory tract below larynx level is usually sterile 16 . Clinically, severity of respiratory tract infection may vary in ranges, from simple illness like common cold to severe illness like pneumonia.
By inhalation and contaminated micro droplets, micro-organisms enters the lower respiratory tract. Increased number of aspiration of nasopharyngeal flora and long time exposure of contaminated air makes lung parenchyma vulnerable to invasion of micro organisms. Particles which are less than 5 micro meter in diameter reach the alveoli very easily. Particles of size larger than 10 micro meter get trapped in nasal secretions 17 . Particles of size more than 100 micrometer are precipitated easily and are not easily inhaled.
In upright position the inhaled micro organism deposit is higher in the lower lobe, since lower lobe has plenty of ventilation in upright position. Comparing to other type of pneumonia, inhalation pneumonia is very easily affected and more often are due to micro organisms which are
size less than 5 micrometer, high inoculums carrier, in transit time it survive long enough, remain suspend in the air, can travel long in air, defeat local host defense mechanism easily.
There are several ways through which infection spreads such as aerosol inhalation, aspiration, oropharyngeal secretion, haematogenous spread and reactivation of latent micro organisms 18 .
Defence Mechanism
Lung maintains its bacteria free position by immune respiratory defence mechanism and non immune respiratory defence mechanism, which works very effectively at different levels of lungs.
The respiratory defence mechanisms are located in different levels which are as follows.
a. Nasopharynx acts as defence mechanism by presence of nasal
hair and turbinates, IgA secretions and mucocilliary apparatus.
b. Trachea and bronchi acts as defence mechanism by cough,
epiglottic reflex, immunoglobin ( IgG, IgM and IaA) secretions
and mucocilliary apparatus.
c. Terminal airways and alveoli acts as defence mechanism by
pulmonary lymphatics, cell mediated immunity, alveolar
macrophages, cytokines( interleukin – 1, tumor necrosis factor),
alveolar lining fluid (surfactant, complement, Ig, fibronectin)
and polymorphonuclear leukocytes.
Sometimes the above said defence mechanisms may get impaired, which leads to failure to defence the microbes entering in to lungs and cause damage causing infection. They are as follows, o Depressed glottis reflex and cough
This may leads to the aspiration of gastric content in old age patients and patients with thoracoabdominal surgery, COPD and neuromuscular disease.
2. Alteration of normal oropharyngeal flora
Microorganism colonization is oropharynx is prevented by presence of normal flora, complement and local immune globulins mainly immunoglobulin A. some chronic systemic disorders, malnutrition, diabetes and alcoholism reduces salivary fibronectin levels and increases gram negative bacilli colonization. Resistant gram negative bacilli colonization may be due to suppression of the normal oral flora due to over usage and misusage of inappropriate antibiotics.
3. Mucociliary apparatus mechanism impairment
Physical properties of mucus and effective ciliary motion causes effective mucociliary clearance. Airway surface fluid are produced by surface epithelial globlet cells and sub mucosal glands. This fluid consists
of lower layer of non gel liquid and upper gel like mucin. The cilia pushes gel towards mouth. Exposure to hot or cold air, chronic cigarette smoking, some harmful gases and viral respiratory infections causes damage to mucous from larynx up to the terminal bronchioles.
4. Altered Consciousness
During deep sleep approximately 50% of oropharyngeal secretions are aspirated by normal healthy individual. Oropharyngeal contents, which contains over 100 million bacteria per milliliter of secretion may often aspirated in some conditions like alcoholism, seizure, coma, CNS depressant drugs over dosage and cerebro vascular accidents.
5. Immune dysfunction :
Infections caused by pathogenic microorganisms are fought with the help of immune system including respiratory tract. recognition of antigens by B and T lymphocytes are important for immune response 19 .
Such responses are regulated by macrophages, mast cells, neutroplils, pulmonary dendritic cells and eosinophils. Immunosuppressive therapies, disorders of lymphocytes, granulocytes and congenital/ acquired immune deficiencies may predispose to infection like pneumonia.
6. Dysfunction of alveolar macrophage :
Alveolar macrophages are very highly effective phagocytic cells which are capable of scavenging very wide spectrum of the particulate bodies. Lysosomal system breaks micro organism, substance escapes this will be isolated in secondary lysosomes and stay there for life span of macrophages. Generation of reactive oxygen species, toll like receptor protein and nitric oxide formation other important macrophages. By causing impairment of alveolar macrophages,chronic anaemia, hypoxemia, prolonged starvation, respiratory viral infection and chronic cigarette smoking helps in the occurrence of pneumonia 20 .
CAP mainly caused by bacteria or virus. Most of the time viral infection follows to bacterial infection. Invasion of bacteria to lung parenchyma causes the filling of alveoli with inflammatory exudates which causes Consolidation or solidification of lung tissue. There are different factors which determines the form of pneumonia such as host reaction, specific etiologic agent and extend of the involvement 21 .
On basis of anatomic distribution, bacterial pneumonia divided into two gross patterns like Lobar pneumonia and lobular broncho pneumonia.
Lobar pneumonia is acute bacterial infection causing fibrinosuppurative consolidation of a entire lobe or the large portion of a single lobe.
Broncho pneumonia causes patchy consolidation of lung.
Many a times the anatomical pattern of classification overlaps and its really difficult to differentiate what kind of pneumonia it is. For example use of antibiotic restricts the progression of disease and express as subtotal infection or sometimes diffuse patchy consolidation expresses as lobar pattern. Moreover, an organism can cause lobar pneumonia in one patient and can cause broncho pneumonia in other patient 22 . From clinical stand point is very important to determine the extent of the disease and identify the causative organism.
The inflammatory response in Lobar pneumonia is classified in four stages as follows.
1. Congestion
2. Red hepatization
3. Grey hepatization
4. Resolution
In recent days use of antibiotics halts or slows down the progression of disease.
1. Congestion
In Initial stage of consolidation, lung is red, boggy and heavy, which is characterized by intraalveolar fliud with neutrophils, vascular engorgement and presence of plenty of bacteria's.
o Red hepatization
The red hepatization stage characterized by alveolar space filled with massive exudates with fibrin, neutrophils and red cells. The lobe appears airless, firm, red and liver like consistency. So the stage is termed as Red Hepatization. o Grey Hepatisation :
The red cell disintegrate progressively and fibrinoeuppurative exducate persistence makes lung surface dry and gives gross appearance of grayish brown. This stage is Gray Hepatization. o Resolution :
In final Resolution stage, fibrins, bacteria and neutrophils get cleared and in alveolar space macrophages reappears, as the inflammatory response.
Pneumonia Caused by Different Microbes :
Infection caused by different microbes are explained below 23 ,
Streptococcus Pneumoniae
The most common and most important cause of CAP is
Streptococcus Pneumoniae. The very most important step in diagnosing acute pneumonia is Gram stained sputum examination. It is more specific to Isolate pneumococci from blood culture and in early phases of this illness, cultures may be positive in 20% to 35% of patients with
pneumonia 24 . The good evidence of streptococcus pneumonia are presence of lancet shaped diplococcic and neutrophils containing the typical gram positive organisms. False positive results may be often obtained by this kind of method since S. pneumoniae is an endogenous flora. At every possible time antibiotic sensitivity must be checked 25 .
Haemophilus influenza
CAP caused by both encapsulated and un-encapsulated forms of haemophilus influenza. In Adults infections like as, cystic fibrosis, chronic bronchitis and bronchiectasis are at high risk to get developed.
Acute exacerbation of COPD is caused by H.influnzae.
The encapsulated form can cause a life-threatening condition of pneumonia in children, followed by a respiratory viral infection. In children suppurative meningitis and epiglottitis are caused by
H.influnzae, but significantly reduced due to vaccination in infants.
Staphylococcus aureus
Nosocomial pneumonia is mainly caused by S.aureus . S. aureus is an most important cause of secondary bacterial pneumonia after viral respiratory illnesses, in healthy adults and children, for example influenza in both adults and children and measles in children. In intravenous drug abuse individuals Staphylococcal pneumonia
association staphylococcal endocarditis on the right side . Staphylococcal pneumonia is associated with complications like empyema and lung abscess 26 .
Moraxella catarrhalis
Along with H. influenza andS . pneumonia, otitis media is caused by M. catarrhalis in children. In adults, M. catarrhalis is the second common bacterial cause of COPD acute exacerbation. In the elderly, cause of bacterial pneumonia is recognized as M.catarrhalis.
Klebsiella pneumonia
Gram negative bacterial pneumonia is most frequently caused by
K. pneumoniae. It frequently afflicts malnourished and debilitated persons, particularly with chronic alcoholic person. It is character by
Thick and gelatin like sputum, and so the organism secretes lots of viscid capsular polysaccharides, in which the person may feel difficulty in coughing up.
Legionella pneumophila
In upper respiratory tract, without pneumonic symptoms, self limiting infection caused by L. pneumophila is Pontiac fever. It is the causative agent of legionnaire disease, which is a namesake for the
sporadic and epidemic forms of pneumonia caused by L.pneumophilia. In persons with predisposing condition such as renal, cardiac, hematologic or immunologic disease Legionella pneumonia is common. It flourishes in the artificial water environments, such as domestic water supply tubing system and water cooling towers . Aspiration of contaminated water or inhalation of aerosol organisms are thought to be the mode of transmission.
Legionella pneumonia may require frequent hospitalization , may be severe and fatality rate for immune suppressed individuals may vary from 30% to 50%. More susceptible person for this organism are Organ transplant recipients. In sputum presence of positive fluorescent antibody and in Urine Legionella antigen demonstration are the Rapid diagnosis methods for Legionella pneumonia. Moreover the gold standard of diagnosis of Legionella pneumonia is Culture.
Pseudomonas aeruginosa
P. aeruginosa is seen most commonly in nosocomial pneumonia.
Due to association with cystic fibrosis infection we discuss this organism with community acquired pathogens. In condition such as mechanical ventilated patients, neutropenic persons, extensive burn patients and patients who are secondary to chemotherapy, Pseudomonas pneumonia is
more common. P.aeruginosa spreads extrapulmonarly and in infection sites it invades blood vessels.
On Histopathological examination, it shows coagulation necrosis of lung parenchyma with the necrotic blood vessel walls invaded by organism, which is defined as Pseudomona s vasculitis. Since death often occurs in few days of infection, Pseudomonas always described as a fulminant disease.
Clinical features
CAP generally presents in two forms as typical and atypical 27 .
Typical form
Streptococcal pneumonia is most common pathogen causing typical form of CAP. Though sometime anaerobic and aerobic flora of oral cavity and H. influenza may also cause typical infection. The typical pneumonia is characterized by the sudden onset of fever, with or without chills, shortness of the breath, productive cough with purulent sputum, haemoptysis, pleuritic chestpain, Tachypnoea, tachycardia and dullness as signs of pulmonary consolidation , rales and bronchial breath sounds may expressed on physical examination.
Atypical Form :
Atypical pneumonia is mainly caused by M. pneumoniae, but it also can caused by Pneumocystis carinii oral anaerobes, and Chlamydia pneumoniae 28 . Unlike typical form, it is characterized by fever which is gradual in onset, shortness of breath and dry cough. Some extra pulmonary symptoms like myalgia, headache, fatigue, nausea, vomiting, sore throat and diarrhea are also characterized in atypical pneumonia. On chest x-ray there are only minimal sign changes compared to typical form.
CAP may sometimes expresses Non respiratory symptoms in lower lobe pneumonia, which may expresses as rigidity, abdominal pain and ileus. In severe forms patients may present with symptoms like marked confusion, and also present as cerebellar dysfunction, meningitis, metabolic disturbances and evidence of hypoxia 29 . Patients who are severely ill may some times present with septic shock and with the evidence of organ failure.
We cannot rule out or confirm the pneumonia just only by the information obtained from patient as history or by our physical examination with the adequate accuracy.
Diagnosis
The physician by asking the patient about his living circumstances, his occupation, history of travel, contact history with patients and exposure to animal history, may get clue about microbial etiology of the infection. the clinical and radiological methods may helps in concluding the diagnosis of pneumonia. And the laboratory infection will aid us to conclude the etiology of the infection 30 .
Clinical Diagnosis
Infectious diseases and noninfectious diseases such as chronic bronchitis - acute exacerbations, acute bronchitis, radiation pneumonitis, pulmonary embolism and heart failure are the differential diagnosis of
CAP. Very careful history collecting of a patients is more important. For example worsening pulmonary edema suggested by known cardiac disease, Secondaries to irradiation therapy suggested by underlying carcinoma 31 . Epidemiologic clues, like patients recent travel history to known endemic areas, for example travel to south east Asia, may give alert to physician to reach the specific possibilities.
Moreover, the specificity and sensitivity of the physical examination findings are really very less as an averaging sensitivity of
58% and specificity of 67%.
Radiological Diagnosis
Since there is very less sensitivity and specificity in physical findings is really necessary to differentiate CAP from the other conditions by using chest radiograph 32 . Sometimes etiological diagnosis can be suggested by radiological results, like tuberculosis is suggested by cavitations in the upper lobe and Staphylococcus aureus infection suggested by pneumatoceles. In outpatients, treatment for CAP is done with the help of clinical and the radiologic assessments, because most of the time laboratory results are unavailable to start initial treatment.
In some cases, the availability of rapid diagnosis and treatment is very important such as, for influenza virus infection, rapid diagnosis is very important to start anti-influenza treatment and for the secondary prevention of infection 33 . Usually CT is not necessary, but sometimes in a patient with foreign body or tumor causing post obstructive pneumonia, it is more useful to diagnose 34 .
Etiological Diagnosis
Only by clinical presentation it is difficult to determine the etiology of infection. Instead, support of laboratory results is more useful for the physician to diagnose. For patients in the intensive care unit, there is no data to prove the efficacy between treatment for a specific pathogen and empirical therapy. This leads to the questioning of microbial etiology establishment, mainly about cost effectiveness of diagnostic testing.
Moreover, there are number of reasons that can leads to attempt an etiologic diagnosis. Narrowing of the beginning empirical therapy is done by unexpected pathogen identification, that reduces the risk of resistance and also helps incorrect antibiotic selection 35 . Appropriate empirical therapy and resistance to antibiotics are difficult to finalize without susceptibility data and culture.
Blood Culture
The blood culture results gives very less useful information in spite of blood samples collected before the starting of antibiotic theraphy 36 .
Blood culture report of hospitalized CAP patients are positive only approximately 5–14%, and S. pneumonia is isolated organism most frequently because of lack of significant outcome and of low yield values
blood culture is no more considered as investigation for patient infected with CAP.
Because of all empirical treatment which we use covers pneumococcus, blood cultured patients gets positive results. However, susceptibility data may allow narrowing of antibiotic therapy in appropriate cases. Patients of high risk criteria such as asplenia, neutropenia secondary to pneumonia, chronic liver disease or severe CAP or complement deficiencies blood culture should be done.
Polymerase chain Reaction
Polymerase chain reaction test is useful for micro organisms like mycobacteria and L. pneumophilus. Amplification of DNA and RNA of microorganisms done by Polymerase chain reaction tests. Sometimes there is a special test called multiplex PCR which helps in detection of the nucleic acid of C.pneumoniae, M.pneumoniae, and Legionella spp 37 .
However, for research study purposes the PCR assays is limited.
Also it helps us to identify the patients who needs intensive care unit admission. In pneumococcal pneumonia patients, by PCR, documentation of an increased bacterial load is associated with an increased risk of patient need for mechanical ventilation, septic shock and death.
Gram staining and sputum culture
The sputum Gram's stain is used to assure ensure that a sample which collected is suitable for culture. However, certain pathogens are identified by their characteristic appearance, by Gram's stain like S. aureus, S. pneumonia and gram-negative bacteria. Sputum sample said to be adequate for culture, only if it contains squamous epithelial cells <10 and >25 neutrophils per low power field. The Gram's stain and cultures specificity and sensitivity are highly variable. For example in a confirmed bacteremic pneumonia, sputum samples cultures is positive only about 50%.
The etiologies of milder and severe form of CAP are somewhat different, so there is a greatest benefit in the staining and culturing collected respiratory secretions. Physician should be careful with resistant pathogens and/or unsuspected pathogens and to start with correct modification of therapy. Sometimes specific stains for specific microbes may be very useful
Many patients would have started antibiotic treatment and in some elderly patients are not able to produce enough amount of sputum for staining and culture, This may interfere in the staining and culture procedures. Because of dehydration the amount of sputum secreted is
very less and when we try to correct the dehydration, there is increase in the production of sputum and it get infiltrate in lungs, which shows infiltrative signs in chest x rays.
Bronchoalveolar lavage and deep suction aspirate sample collected from patients who are intubated and admitted in ICU when microbiology examination done immediately has a very high yield on culture.
Fig : Gram Positive diplococci in sputum gram stain. S.pneumonia
shown in arrows.
Serological Examination
Between convalescent phase and acute phase serum samples, diagnostics of infection is generally considered by a titer rise of fourfold rise in specific IgM antibody. In the olden days, atypical pathogen identification and also selected unusual causative organisms such as
Coxiella burnetii is done by serologic tests. But now a days, however not commonly used because of the time taken to produce the convalescent phase samples final result.
Testing the Antigens
In urine there are Two antigenic tests available to detect certain
Legionella and pneumococcal antigens. The sero group 1 detected by this test used for community acquired Legionnaires disease. The urine antigen test for pneumococcal is also quite specific and sensitive about >90% and 80% respectively. The specificity and sensitivity of the urine antigen test for Legionella are as very high as 99% and 90%, respectively.
Even after the beginning of antibiotic therapy, antigens can be detected by both tests. The test is mostly reliable, though false-positive results obtained with samples collected from children colonized by pneumococcus. Some other test has poor sensitivity like rapid and the
direct fluorescent antibody tests for respiratory syncytial virus and influenza virus.
Management
Assessment of the severity of the disease is done by several criteria. Due to better prognostic correlation and its simplicity, CURB 65 is most commonly and most often used. Several assessment of pneumonia severity are explained as follows 38 .
CRB 65
• Confusion state of patient
• Respiratory rate of patient more than or equal to 30/min
• Low blood pressure, that is systolic blood pressure less than
or equal to 90mmHg or Diastolic Blood Pressure less than
or equal to 60mmHg.
• Age of patient more than or equal to 65.
CURB 65
• Confusion state of patient
• Urea level more than or equal to 7 mmol/lit
• Respiratory rate of patient more than or equal to 30/min
• Low blood pressure, that is systolic blood pressure less than
or equal to 90mmHg or Diastolic Blood Pressure less than
or equal to 60mmHg 39 .
• Age of patient more than or equal to 65
SMRT CO
• Low systolic blood pressure less than 90mmHg
• Multi lobar involvement in chest X ray
• Respiratory rate of patient more than or equal to 25/min
• Tachycardia, Pulse more than or equal to 125/min
• Confusion state
• Poor oxygenation, Spo2 less than 93%, Pao2 less than
70mmHg.
SMART COP
• Low systolic blood pressure less than 90mmHg
• Multi lobar involvement in chest X ray
• Low albumin level about less than 3.5g/dl
• Respiratory rate of patient more than or equal to 25/min
• Tachycardia, Pulse more than or equal to 125/min
• Confusion state
• Poor oxygenation, Spo2 less than 93%, Pao2 less than
70mmHg.
• Low pH, less than 7.35.
ATS IDSA: Minor criteria
• Pao2/Fio2 ratio less than or equal to 250
• Respiratory rate of patient more than or equal to 30/min
• Disorientation/ confusion
• Infiltrates in multi lobes
• WBC count less than 4000 cells per micro-litre
• BUN level more than 20mg/dl
• Core temperature less than 36 degree celcius
• Platelet count less than 100,000 cells per cubic millimeter.
Major criteria
• Vasopressor needed septic shock
• Mechanical ventilator – invasive.
Pneumonia Severity Index :
Pneumonia severity Index used in the prediction of mortality of pneumonia. These index are used only in the initial stage of the severity of pneumonia because it has its own inherent problem and has non- absolute parameters 40 .
In PSI method, there are 20 variables in which points are given for each, such as coexisting illness, age, abnormal laboratory and physical findings. Patients are assigned on different classes with mortality rates on basis of scores obtained by this method. Some Clinical trials shows that routine use of PSI results obtained, reduces the rate of hospital administration in early stages of the disease.
PSI alone cannot be used to decide whether patient needed ICU care or not. To conclude that, other data also should be used along with PSI.
Since PSI needed to taken in account about 20 parameters, which is very difficult to apply during emergency situations, there comes other method which is very easy to apply, that is CURB 65. But neither of criteria used for the decision taking purpose whether the patient needed ICU or not.
Best method for this purpose is used by the severity criteria of patients given by the American Thoracic Society and the Infectious Diseases
Society of America.
Admission of patient in ICU should fulfill at least one of the following criteria:
1. Respiratory frequency more than 30 beats per minute.
2. Severe respiratory failure
3. Patient when needs mechanical ventilation
4. Pao2/Fio2 less than 250 mmHg, if it is Chronic obstructive
Pulmonary disease it should be less than 200 mmHg.
5. Severe instability in haemodynamics.
• Vaso active drugs needed for more than 4 hours
• Diastolic blood pressure less than 60 mmHg or systolic
blood pressure less than 90 mmHg.
• In the hypovolaemic absence urine output less than 20
ml/hr.
6. Other severe organ failures.
7. Spread of pneumonia in radiological feature, that is within 48 hours
of admission opacity size increase by 50% or get greater.
8. Haematologic or Metabolic criteria :
• Dialysis required due to acute renal failure.
• Severe acidosis of pH less than 7.30
• Severe DIC.
The following things are should be in mind before starting a patient with empirical treatment :
• Compliance, cost of drug and safety
• Pharmacodynamics and pharmacodynamics of antibiotics
• Recently administered drugs
• Local susceptible pattern Knowledge.
• Most common Pathogen.
Resistance to Antibiotics
Now a days Antibiotics are mostly misused in several ways that leads to resistance to several antibiotics. Resistance to antibiotics is really a major problem that interferes quality of the treatment. Currently, for
CAP,CA-MRSA and S. pneumoniae has major issue of resistance 41 .
CA MRSA :
Recently identified, Phenotypically and genotypically distinct strains of CAP and strains that are acquired from hospitals causes CA
MRSA 42 . Most infections of later strains are acquired may be directly or indirectly by contacting the environment of health care profession and now it is called as HCAP 43 . In recent days, in hospitals, strains acquired from hospitals are displace by strains of CA-MRSA , which hints the increasing in strength of newer strains.
S.pneumonia
Generally, resistance to pneumococcal infection acquired by
1. Natural Transformation Process
2. By remodeling and DNA incorporation
3. Certain gene mutation.
Beta lactam drug resistance is mainly due to penicillin binding proteins affinity is low. Risk factors of pneumococcal penicillin-resistant infection include an age of >65 years or <2 years, recently used antimicrobial therapy, HIV infection, recent hospitalization, and day care hospital attendance 44 .
Like penicillin resistance, macrolides resistance is increasing by several mechanisms. In Europe macrolide resistance is very high and more common, Some times Pneumococcal infection shows resistance to other antibiotics like fluoroquinolones reported 45 .
Resistant to drugs of more than three antimicrobial with mechanism of the action also different are considered as MDR. The antibiotic used in last 3 months is very important risk factor for pneumococcal antibiotic-resistant infection. Hence, a patient's prior antibiotic history in treatment plays critical role in avoiding use of the inappropriate antibiotics46 .
Table : Antibiotic Treatment of CAP
Complications
Complications of CAP are divided as Local and general complications. Which are listed below 47 ,
General complications:
• Meningitis,
• Septic arthritis
• Skin rashes
• Peritonitis
• Thrombocytopenia
• Haemolytic anaemia
• Gastroenteritis.
• Failure in circulation like myocarditis and pericarditis
Local Complications:
• Respiratory failure
• Delayed resolution of lung parenchyma
• Empyema
• Lung abscess
• Pleural effusion
• Spread to other lobes.
Like all other infections in severe conditions, CAP also has complications that include multi organ failure, shock, Respiratory failure, comorbid illnesses exacerbation and coagulopathy . Most important complication of CAP are pleural effusion, lung abscess and metastatic infection. Lung abscess sometimes occur with aspiration or with CA-
MRSA, S. pneumonia or with P. aeruginosa 48 .
Unusual complication like Metastatic infection needs physician attention immediately where proper workout and treatment is necessary.
For therapeutic and diagnostic purposes Pleural effusion must be tapped and drained 49 . Aspiration pneumonia is a infection of mixed polymicrobes that involves both anaerobes and aerobes. In both conditions, drainage must be done, and suspected pathogen covering antibiotics should be given.
Prevention
The Vaccination is very important preventive method. As recommended by ACIP pneumococcal and influenza vaccines must be followed 50 . Even patients not having obstructive lung diseases, due to pneumococcal infection risk, smokers must be strictly warned for sessation of smoking.
In the outbreak of influenza, patients who are not protected and capable of getting complications must be vaccinated immediately and chemoprophylaxis should be given with zanamivir or oseltamivir for duration of 2 weeks till antibody induced by vaccine, reaches high 51 .
Immunological memory of long term is given by 7 valent conjugated pneumococcal vaccine which is available now a days. This vaccine given to children produces decrease in the pneumococci of antimicrobial resistant type. Also in adults and children it decreases pneumococcal disease incidence. However, following the vaccination, non vaccine serotypes are used to replace vaccine serotypes for subsequent period.
MATERIALS AND METHOD S
SOURCE OF STUDY:
Data consists of primary data collected by the principal investigator directly from the patients who are admitted in the Government
Coimbatore Medical College and Hospital.
DESIGN OF STUDY : Cross sectional study
PERIOD OF STUDY : One year, 2016- 2017.
SAMPLE SIZE : 50
• 50 patients with Community acquired pneumonia.
INCLUSION CRITERIA:
• Patients with age > than 12 years
• Patients having clinical features like fever ( temperature >
37.8degree celcius) , cough ( less than 4 weeks), production
of purulent sputum, chest pain, breathlessness.
• Radiological evidence of pneumonia.
EXCLUSION CRITERIA
Patients having hospital acquired pneumonia, HIV positive patients, tuberculosis, immune compromised, aspiration pneumonia, pulmonary infarction.
METHODOLOGY
The study is will be undertaken on the patients attending medicine out patient department and admitted in the Coimbatore Medical College and Hospital, Coimbatore during the study period ( 2016 to 2017). A total of 50 patients with Community acquired pneumonia are included in the study based on the inclusion/exclusion criteria.
The list of the patients enrolled in the study is appended along with the dissertation. The study excludes minors, pregnant women, mentally- ill and non-volunteering patients.
The study is proposed to be conducted after obtaining informed signed consent from the patients. The duration of the study is one year from 2016 to 2017. The principal investigator, after obtaining informed signed consent from the patients to participate in the study, collects their baseline characteristic details and physical examination details to identify
Community acquired pneumonia.
INVESTIGATIONS :
• Complete Haemogram
• Sputum culture and sensitivity
• Blood culture
• Chest x-ray posterior-anterior view
• CT chest
• Renal function test
• Liver function test
RESULTS
AGE DISTRIBUTION
Table 1: Age Distribution in decades, in the Study Population
AGE (IN YEARS) NO OF PATIENTS PERCENTAGE
< 40 10 20%
41-50 9 18%
51-60 16 32%
> 60 15 30%
AGE DISTRIBTION 16 15 10 9
< 40 41-50 51-60 > 60
Chart 1 : Age Distribution in decades, in the Study Population
Table 2- Age Distribution in the Study Population
AGE (IN YEARS) NO OF PATIENTS PERCENTAGE
MORE THAN 50 31 62%
LESS THAN 50 19 38%
AGE DISTRIBUTION
19
31
MORE THAN 50 LESS THAN 50
Chart 2 – Age Distribution in the Study Population
Table 3 – Sex Distribution in the Study Population
SEX NO OF PATIENTS PERCENTAGE
MALE 37 74%
FEMALE 13 26%
SEX DISTRIBUTION
26%
MALE FEMALE
74%
Chart 3 – : Sex Distribution in the Study Population
Table 4 : Age Vs Sex
AGE DISTRIBUTION
SEX MORE THAN 50 LESS THAN 50
MALE 24 13
FEMALE 7 6
P VALUE - 0.481
NON SIGNIFICANT
SEX
MORE THAN 50 LESS THAN 50 24 13 7 6
M A L E FEMALE
Chart 4 : Age Vs Sex
Table 5 : Cough Manifestation in The Study Population
COUGH NO OF PATIENTS PERCENTAGE
PRESENT 50 100%
ABSENT 0 0%
COUGH 60 50 50
40
30
20
10 0 0 PRESENT ABSENT
NO OF PATIENTS
Chart 5 : Cough Manifestation in The Study Population
Table 6 : Cough Vs Age
COUGH AGE DISTRIBUTION
MORE THAN 50 LESS THAN 50
PRESENT 31 19
ABSENT 0 0
P VALUE – NIL
COUGH VS AGE
35 31 30 25 19 20 15 10 5 0 0 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 6 : Cough Vs Age
Table 7 : Fever Manifestation in the Study Population
FEVER NO OF PATIENTS PERCENTAGE
PRESENT 49 98%
ABSENT 1 2%
FEVER
ABSENT, 1
PRESENT, 49
Chart 7 : Fever Manifestation in the Study Population
Table 8 : Age Vs Fever
AGE DISTRIBUTION
FEVER MORE THAN 50 LESS THAN 50
PRESENT 31 18
ABSENT 0 1
P VALUE - 0.197
NON SIGNIFICANT
AGE VS FEVER
PRESENT ABSENT 31 18 1 0
MORE THAN 50 LESS THAN 50
Chart 8 : Age Vs Fever
Table 9 : Expectoration in the Study Population
EXPECTORATION NO OF PATIENTS PERCENTAGE
PRESENT 49 98%
ABSENT 1 2%
EXPECTORATION
2%
PRESENT ABSENT
98%
Chart 9 : Expectoration in the Study Population
Table 10 : Age Vs Expectoration
AGE DISTRIBUTION
EXPECTORATION MORE THAN 50 LESS THAN 50
PRESENT 30 19
ABSENT 1 0
P VALUE - 0.429
NON SIGNIFICANT
EXPECTORATION 35 30 30 25 19 20 15 10 5 1 0 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 10 : Age Vs Expectoration
Table 11 : Pleuritic Chest in the Study Population
PLEURITIC CHEST NO OF PATIENTS PERCENTAGE
PRESENT 43 86%
ABSENT 7 14%
PLEURITIC CHEST
14%
PRESENT ABSENT
86%
Chart11 : Pleuritic Chest in the Study Population
Table 12 : Age Vs Pleuritic Chest Pain
AGE DISTRIBUTION
PLEURITIC CHEST MORE THAN 50 LESS THAN 50
PRESENT 29 14
ABSENT 2 5
P VALUE - 0.049
SIGNIFICANT
PLEURITIC CHEST
PRESENT ABSENT 29 14 5 2
MORE THAN 50 LESS THAN 50
Chart 12 : Age Vs Pleuritic Chest Pain
Table 13 : Dyspnoea in the Study Population
DYSPNOEA NO OF PATIENTS PERCENTAGE
PRESENT 43 86%
ABSENT 7 14%
DYSPNOEA
ABSENT, 7
PRESENT, 43
Chart13 : Dyspnoea in the Study Population
Table 14 : Age Vs Dyspnoea
AGE DISTRIBUTION
DYSPNOEA MORE THAN 50 LESS THAN 50
PRESENT 29 14
ABSENT 2 5
P VALUE - 0.049
SIGNIFICANT
DYSPNOEA VS AGE 35 29 30 25 20 14 15 10 5 5 2 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 14 : Age Vs Dyspnoea
Table 15 : Hemoptysis in the Study Population
HEMOPTYSIS NO OF PATIENTS PERCENTAGE
PRESENT 8 16%
ABSENT 42 84%
HEMOPTYSIS
16%
PRESENT ABSENT
84%
Chart15 : Hemoptysis in the Study Population
Table 16: Age Vs Hemoptysis
AGE DISTRIBUTION
HEMOPTYSIS MORE THAN 50 LESS THAN 50
PRESENT 7 1
ABSENT 24 18
P VALUE - 0.105
NON SIGNIFICANT
HEMOPTYSIS VS AGE
PRESENT ABSENT
30
25 24 20
15 18
10
5 7 1 0 MORE THAN 50 LESS THAN 50
Chart 16 : Age Vs Hemoptysis
Table 17 : Crepitation in the Study Population
CREPITATION NO OF PATIENTS PERCENTAGE
PRESENT 49 98%
ABSENT 1 2%
CREPITATION
2%
PRESENT ABSENT
98%
Chart17 : Crepitation in the Study Population
Table 18 : Age Vs Crepitation
AGE DISTRIBUTION
CREPITATION MORE THAN 50 LESS THAN 50
PRESENT 31 18
ABSENT 0 1
P VALUE - 0.197
NON SIGNIFICANT
CREPITATION VS AGE
35 31 30 25 20 18 15 10 5 0 1 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 18 : Age Vs Crepitation
Table 19 : Cyanosis in the Study Population
CYANOSIS NO OF PATIENTS PERCENTAGE
PRESENT 8 16%
ABSENT 42 84%
CYANOSIS
8, 16%
PRESENT ABSENT
42, 84%
Chart19 : Cyanosis in the Study Population
Table 20 : Age Vs Cyanosis
AGE DISTRIBUTION
CYANOSIS MORE THAN 50 LESS THAN 50
PRESENT 8 0
ABSENT 23 19
P VALUE - 0.016
SIGNIFICANT
CYANOSIS VS AGE 25 23 19 20
15
10 8
5 0 0 PRESENT ABSENT
MORE THAN 50 LESS THAN 50
Chart 20 : Age Vs Cyanosis
Table 21 : Bronchial Breath Sounds in the Study Population
BRONCHIAL BREATH NO OF PATIENTS PERCENTAGE SOUNDS
PRESENT 48 96%
ABSENT 2 4%
BRONCHIAL BREATH SOUNDS
4%
PRESENT ABSENT
96%
Chart21 : Bronchial Breath Sounds in the Study Population
Table 22 : Age Vs Bronchial Breath Sounds
AGE DISTRIBUTION
BRONCHIAL BREATH SOUNDS MORE THAN 50 LESS THAN 50
PRESENT 30 18
ABSENT 1 1
P VALUE - 0.721
NON SIGNIFICANT
BRONCHIAL BREATH SOUNDS VS AGE 35 30 30 25 20 18 15 10
5 1 1 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart22 : Age Vs Bronchial Breath Sounds
Table 23 : Altered Sensorium in the Study Population
ALTERED SENSORIUM NO OF PATIENTS PERCENTAGE
PRESENT 3 6%
ABSENT 47 94%
ALTERED SENSORIUM
3
PRESENT ABSENT
47
Chart23 : Altered Sensorium in the Study Population
Table 24 : Age Vs Altered Sensorium
AGE DISTRIBUTION
ALTERED SENSORIUM MORE THAN 50 LESS THAN 50
PRESENT 3 0
ABSENT 28 19
P VALUE - 0.162
NON SIGNIFICANT
ALTERED SENSORIUM VS AGE 30 28
25 19 20
15
10
5 3 0 0 PRESENT ABSENT
MORE THAN 50 LESS THAN 50
Chart24 : Age Vs Altered Sensorium
Table 25 : Pleural Effusion in the Study Population
PLEURAL EFFUSION NO OF PATIENTS PERCENTAGE
PRESENT 3 6%
ABSENT 47 94%
PLEURAL EFFUSION
6%
PRESENT ABSENT
94%
Chart25 : Pleural Effusion in the Study Population
Table 26 : Age Vs Pleural Effusion
AGE DISTRIBUTION
PLEURAL EFFUSION MORE THAN 50 LESS THAN 50
PRESENT 3 0
ABSENT 28 19
P VALUE - 0.162
NON SIGNIFICANT
PLEURAL EFFUSION VS AGE
PRESENT ABSENT 28 19 3 0
MORE THAN 50 LESS THAN 50
Chart 26 : Age Vs Pleural Effusion
Table 27 : Smokers in the Study Population
SMOKING NO OF PATIENTS PERCENTAGE
PRESENT 28 56%
ABSENT 22 44%
SMOKING
44% 56% PRESENT ABSENT
Chart27 : Smokers in the Study Population
Table 28 : Age Vs Smokers
AGE DISTRIBUTION
SMOKING MORE THAN 50 LESS THAN 50
PRESENT 21 7
ABSENT 10 12
P VALUE - 0.033
SIGNIFICANT
SMOKING VS AGE
PRESENT ABSENT
25 21 20
15 12 10 10 7
5
0 MORE THAN 50 LESS THAN 50
Chart 28 : Age Vs Smokers
Table 29 : Alcoholics in the Study Population
ALCOHOLIC NO OF PATIENTS PERCENTAGE
YES 22 44%
NO 28 56%
ALCOHOLIC
44% YES 56% NO
Chart29 : Alcoholics in the Study Population
Table 30 : Age Vs Alcoholics
AGE DISTRIBUTION
ALCOHOLIC MORE THAN 50 LESS THAN 50
YES 18 4
NO 13 15
P VALUE - 0.010
SIGNIFICANT
ALCOHOLIC VS AGE
20 18 15 15 13
10
5 4
0 MORE THAN 50 LESS THAN 50
YES NO
Chart 30 : Age Vs Alcoholics
Table 31 : Diabetes Mellitus Patients in the Study Population
DIABETES MELLITUS NO OF PATIENTS PERCENTAGE
PRESENT 21 42%
ABSENT 29 58%
DIABETES MELLITUS
21
29
PRESENT ABSENT
Chart31 : Diabetes Mellitus Patients in the Study Population
Table 32 : Age Vs Diabetes Mellitus
AGE DISTRIBUTION
DIABETES MELLITUS MORE THAN 50 LESS THAN 50
PRESENT 19 2
ABSENT 12 17
P VALUE - 0.001
SIGNIFICANT
DIABETES MELLITUS VS AGE
PRESENT ABSENT 19 17 12 2
MORE THAN 50 LESS THAN 50
Chart 32 : Age Vs Diabetes Mellitus
Table 33 : Hypertension Patients in the Study Population
HYPERTENSION NO OF PATIENTS PERCENTAGE
PRESENT 18 36%
ABSENT 32 64%
HYPERTENSION
36%
PRESENT 64% ABSENT
Chart33 : Hypertension Patients in the Study Population
Table 34 : Age Vs Hypertension
AGE DISTRIBUTION
HYPERTENSION MORE THAN 50 LESS THAN 50
PRESENT 17 1
ABSENT 14 18
P VALUE - 0.481
NON SIGNIFICANT
HYPERTENSION
20 18 17
15 14
10
5 1 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 34 : Age Vs Hypertension
Table 35 : COPD Patients in the Study Population
COPD NO OF PATIENTS PERCENTAGE
PRESENT 25 50%
ABSENT 25 50%
COPD
PRESENT 50% 50% ABSENT
Chart35 : COPD Patients in the Study Population
Table 36 : Age Vs COPD
AGE DISTRIBUTION
COPD MORE THAN 50 LESS THAN 50
PRESENT 22 3
ABSENT 9 16
P VALUE - 0.001
SIGNIFICANT
COPD VS AGE 25 22
20 16 15
9 10
5 3
0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 36 : Age Vs COPD
Table 37 : Sputum Culture results in the Study Population
SPUTUM CULTURE NO OF PATIENTS PERCENTAGE
GRAM +VE 44 88%
GRAM–VE 6 12%
SPUTUM CULTURE
12%
GROWTH +VE GROWTH -VE
88%
Chart37 : Sputum Culture results in the Study Population
Table 38 : Gram Staining results in the Study Population
GRAM STAINING NO OF PATIENTS PERCENTAGE
GRAM POSITIVE 33 66%
GRAM NEGATIVE 11 22%
NOT CLEAR 3 6%
NO GROWTH 3 6%
GRAM STAINING 35 33
30
25
20
15 11 10
5 3 3
0 GRAM POSITIVE GRAM NEGATIVE NOT CLEAR NO GROWTH
Chart 38 : Gram Staining results in the Study Population
Table 39 : Age Vs Gram Staining
AGE DISTRIBUTION
GRAM STAINING MORE THAN 50 LESS THAN 50
GRAM POSITIVE 20 13
GRAM NEGATIVE 9 2
NOT CLEAR 1 2
NO GROWTH 1 2
P VALUE - 0.138
NON SIGNIFICANT
GRAM STAINING 25
20
15
10
5
0 GRAM POSITIVE GRAM NEGATIVE NOT CLEAR NO GROWTH
MORE THAN 50 LESS THAN 50
Chart 39 : Age Vs Gram Staining
Table 40 : Culture Organisms in the Study Population
CULTURE ORGANISM NO OF PATIENTS PERCENTAGE
STREPTOCOCCUS 28 56%
STAOHYLOCOCCUS 5 10%
KLEBSIELLA 7 14%
PSEUDOMONAS 4 8%
ESHCRECHIA COLI 1 2%
MIXED 2 4%
NO GROWTH 3 6%
CULTURE ORGANISM
3 2 1 4
7 28
5
STREPTOCOCCUS STAOHYLOCOCCUS KLEBSIELLA PSEUDOMONAS ESHCRECHIA COLI MIXED NO GROWTH
Chart40 : Culture Organisms in the Study Population
Table 41 : Age Vs Culture Organism
AGE DISTRIBUTION
CULTURE ORGANISM MORE THAN 50 LESS THAN 50 STREPTOCOCCUS 16 12 STAOHYLOCOCCUS 4 1 KLEBSIELLA 5 2 PSEUDOMONAS 3 1 ESHCRECHIA COLI 1 0 MIXED 1 1 NO GROWTH 1 2
P VALUE -0.770 NON SIGNIFICANT
ORGANISM VS AGE
STREPTOCOCCUS STAOHYLOCOCCUS KLEBSIELLA PSEUDOMONAS ESHCRECHIA COLI MIXED NO GROWTH 16 12 5 4 3 2 2 1 1 1 1 1 1 0
MORE THAN 50 LESS THAN 50
Chart 41 : Age Vs Culture Organism
Table 42 : Blood Culture Growth Results in the Study Population
BLOOD CULTURE GROWTH NO OF PATIENTS PERCENTAGE PRESENT 1 2%
ABSENT 49 98%
BLOOD CULTURE GROWTH
1
PRESENT ABSENT
49
Chart42 : Blood Culture Growth Results in the Study Population
Table 43 : Age Vs Blood Culture Growth
AGE DISTRIBUTION
BLOOD CULTURE GROWTH MORE THAN 50 LESS THAN 50
PRESENT 1 0
ABSENT 30 19
P VALUE - 0.429
NON SIGNIFICANT
BLOOD CULTURE
PRESENT ABSENT 30 19 1 0
MORE THAN 50 LESS THAN 50
Chart 43 : Age Vs Blood Culture Growth
Table 44 : Pleural Fluid Growth Results in the Study Population
PLEURAL FLUID GROWTH NO OF PATIENTS PERCENTAGE PRESENT 2 4%
ABSENT 48 96%
PLEURAL FLUID GROWTH
4%
PRESENT ABSENT
96%
Chart44 : Pleural Fluid Growth Results in the Study Population
Table 45 : Age Vs Pleural Fluid Growth
AGE DISTRIBUTION
PLEURAL FLUID GROWTH MORE THAN 50 LESS THAN 50
PRESENT 2 0
ABSENT 29 18
P VALUE - 0.258
NON SIGNIFICANT
PLEURAL FLUID GROWTH 35 29 30 25 20 18 15 10 5 2 0 0 MORE THAN 50 LESS THAN 50
PRESENT ABSENT
Chart 45 : Age Vs Pleural Fluid Growth
Table 46 : Consalidation in X Ray Results in the Study Population
CONSOLIDATION IN X RAY NO OF PATIENTS PERCENTAGE BILATERAL 12 24%
RIGHT LOWER LOBE 16 32%
RIGHT UPPER LOBE 4 8%
LEFT LOWER LOBE 12 24%
LEFT UPPER LOBE 4 8%
NORMAL 2 4%
CONSOLIDATION IN X RAY
2 4 12
12
4 16
BILATERAL RIGHT LOWER LOBE RIGHT UPPER LOBE LEFT LOWER LOBE LEFT UPPER LOBE NORMAL
Chart 46 : Consolidation in X Ray Results in the Study Population
Table 47 : Age Vs Consolidation in X Ray
AGE DISTRIBUTION CONSOLIDATION IN X RAY MORE THAN 50 LESS THAN 50 BILATERAL 10 2 RIGHT LOWER LOBE 8 8 RIGHT UPPER LOBE 2 2 LEFT LOWER LOBE 8 4 LEFT UPPER LOBE 2 2 NORMAL 1 1
P VALUE - 0.547 NON SIGNIFICANT
CONSOLIDATION IN X RAY
MORE THAN 50 LESS THAN 50 10 8 8 8 4 2 2 2 2 2 1 1
BILATERAL RIGHT RIGHT UPPER LEFT LOWER LEFT UPPER NORMAL LOWER LOBE LOBE LOBE LOBE
Chart 47 : Age Vs Consolidation in X Ray
CONSOLIDATION IN CT NO OF PERCENTAG CHEST PATIENTS E BILATERAL 17 34%
RIGHT LOWER LOBE 16 32%
RIGHT UPPER LOBE 4 8%
LEFT LOWER LOBE 11 22%
LEFT UPPER LOBE 2 4%
Table 48 : Consolidation in CT Chest Results in the Study Population
CONSOLIDATION IN CT CHEST
2
11 17
4
16
BILATERAL RIGHT LOWER LOBE RIGHT UPPER LOBE LEFT LOWER LOBE LEFT UPPER LOBE
Chart 48 : Consalidation in CT Chest Results in the Study
Population
Table 49 : Age Vs Consolidation in CT Chest
AGE DISTRIBUTION
CONSOLIDATION IN CT MORE THAN LESS THAN CHEST 50 50 BILATERAL 14 3
RIGHT LOWER LOBE 8 8
RIGHT UPPER LOBE 2 2
LEFT LOWER LOBE 7 4
LEFT UPPER LOBE 0 2
P VALUE - 0.421
NON SIGNIFICANT
CONSOLIDATION IN CT CHEST 16 14 14 12 10 8 8 8 7 6 4 4 3 2 2 2 2 0 0 BILATERAL RIGHT LOWER RIGHT UPPER LEFT LOWER LEFT UPPER LOBE LOBE LOBE LOBE
MORE THAN 50 LESS THAN 50
Chart 49 : Age Vs Consolidation in CT Chest
Table 50 : Signs And Symptoms in the Study Population
SIGNS & SYMPTOMS NO OF PATIENTS PERCENTAGE COUGH 50 100% FEVER 49 98% EXPECTORATION 49 98% PLEURITIC PAIN 43 86% DYSPNOEA 43 86% HEMOPTYSIS 8 16% CREPITATION 49 98% CYANOSIS 8 16% BRONCHIAL BREATH SOUNDS 48 96% ALTERED SENSORIUM 3 6% PLEURAL EFFUSION 3 6%
SIGNS & SYMPTOMS 120% 100% 98% 98% 98% 96% 100% 86% 86% 80%
60%
40% 16% 16% 20% 6% 6% 0%
Chart 50 : Signs And Symptoms in the Study Population
Table 51 : Co Morbidities in the Study Population
CO MORBIDITIES NO OF PATIENTS PERCENTAGE
SMOKING 28 56%
ALCOHOLIC 22 44%
DIABETES 21 42%
HYPERTENSION 18 36%
COPD 25 50%
CO MORBIDITIES 30 28 25 25 22 21 20 18
15
10
5
0 SMOKING ALCOHOLIC DIABETES HYPERTENSION COPD
Chart 51 : Co Morbidities in the Study Population
Table 52 : Culture Specimens in the Study Population
CULTURE SPECIMEN NO OF PATIENTS PERCENTAGE
SPUTUM 47 94%
BLOOD 1 2%
CULTURE SPECIMEN 47 1
SPUTUM BLOOD
Chart 52 : Culture Specimens in the Study Population
Table 53 : Correlation between Gram Negative Organism and factors
like smoking and COPD
GRAM NEGATIVE (N=11)
FACTORS PRESENT ABSENT
SMOKING 7(63%) 4(37%)
COPD 7(63%) 4(37%)
IN GRAM NEGATIVE PATIENTS 8 7 7 7 6 5 4 4 4 3 2 1 0 SMOKING COPD
PRESENT ABSENT
Chart 53 : Correlation between Gram Negative Organism and
factors like smoking and COPD
Table 54 : Age Vs Duration of Disease
DURATION OF DISEASE (DAYS)
AGE MEAN SD
MORE THAN 50 8.67 2.15
LESS THAN 50 6.89 1.1
P VALUE - 0.002
SIGNIFICANT
MEAN DURATION OF DISEASE 10 9 8.67 8 6.89 7 6 5 4 3 2 1 0 MORE THAN 50 LESS THAN 50
Chart 54 : Mean Duration of Disease
Table 55: Disease Outcome in the Study Population
DISEASE OUTCOME NO OF PATIENTS PERCENTAGE
DIED 3 6%
DISCHARGED 47 94%
DISEASE OUTCOME
6%
DIED DISCHARGED
94%
Chart 55: Disease Outcome in the Study Population
Table 56 : Age Vs Disease Outcome
AGE DISTRIBUTION
DISEASE OUTCOME MORE THAN 50 LESS THAN 50
DIED 3 0
DISCHARGE 28 19
P VALUE - 0.016
SIGNIFICANT
DISEASE OUCOME 30 28
25
20 19
15
10
5 3 0 0 MORE THAN 50 LESS THAN 50
DIED DISCHARGE
Chart 56 : Age Vs Disease Outcome
DISCUSSION
50 Patients with Community Acquired Pneumonia in Coimbatore medical college hospital has taken for this study.
Incidence of age and sex :
< 40 years, totally 10 patients. (20%)
41 – 50 years, 9 patients (18%)
51 – 60 years. 16 patients (32%)
>60 years, 15 Patients. (30%)
• In this study 37 patients were male 74%
13 patients were female 26% More prevalence in male than in female.
• In this study, Age groups >50 years 31 patients
<50 years 19 Patients.
P value - 0.481
Not significant in this study.
Clinical Manifestation:
• Cough present almost in all patients. So no significant difference in
age group.
• Fever present in nearly all patients. Only few patients had absence
of fever.
•
P value – 0.197
No significant difference in age groups
• Expectoration present in nearly all patients
P value – 0.429.
No significant difference in age groups
• Pleuritic chest pain present in 86% of patients.
P value 0.049
More Significant in age >50 years.
• Haemoptysis present in 16% of patients and absent in 84%
No significant difference in age groups
• Crepitations present in almost all patients , 98%
No significant difference in age groups
• Cyanosis present in 84% of patients, absent in 16%
P value 0.016
More Significant in age >50 years
• Bronchian breath sounds present in almost all patients , 96%
P value 0.721
No significant difference in age groups
• Altered sensorium present in 6% of patients, absent in 94%
3 patients aged >50 years had altered sensorium among 28 patients.
Age <50years had no altered sensorium.
Over all clinical manifestation:
• Cough and fever are more common
• Expectoration, pleuritic chest pain, cripitations, bronchial breath
sounds, altered sensorium, pleural effusion observed in only few
patients.
• Cyanosis and hemoptysis seen in very few number of patients, only
around 16%
Risk Factors :
• Smoking observed in 56% of patients with pneumonia.
Smokers of age more than 50 years had pneumonia
So smoking is more significant in patients aged >50 years. With p Value
0.033
• Smoking with 56% and COPD with 50% are more common
associated risk factors for pneumonia
• Alcohol is observed in 44% and absent in 56% of the patients
Alcohol is significant in patients aged >50 years. With p Value
0.010
• Diabetes Mellitus is observed in 42% and absent in 58% of the
patients
Diabetes Mellitus is significant in patients aged >50 years. With p
Value 0.001
• Hypertension present in36% of patients, absent in 64%
No significant difference in age groups, with p Value 0.481.
• COPD is observed in 50% and absent in 50% of the patients
COPD is significant in patients aged >50 years. With p Value 0.001
• Sputum Culture :
Gram Positive in 66% and Gram negative in 22%, undetermined in
6% and no growth in 6%.
No significant difference in age groups, with p Value 0.138.
• Among Gram Positive, Streptococcal pneumonia is observed in
56% of the patients.
• Among gram negative Staphylococcal about 10%, klebsiella 14%,
Pseudomonas 8%, E.Coli 2%, Mixed 4%, No growth 6%. No
significant difference in age distribution.
• Smoking and COPD patients were affected by gram negative
organisms.
• Blood Culture Growth :
Present in 2% and absent in 98% of the patients.
No significant p value in age distribution.
• Pleural Fluid Growth :
Present in 4% and absent in 96% of the patients.
No significant p value in age distribution.
• Sputum culture yields 94% and blood culture yields 2%
• Chest X Ray :
Bilateral Consolidation 24%
Right lower lobe 32%
Right upper lobe 8%
Left lower lobe 24%
Left upper lobe 8%
Normal 4%
No significant p value in age distribution.
Right lower lobe followed by Left lower lobe and bilateral.
• CT Chest :
Bilateral Consolidation 34%
Right lower lobe 32%
Right upper lobe 8%
Left lower lobe 22%
Left upper lobe 4%
No significant p value in age distribution.
Bilateral followed by Right lower lobe and then Left lower lobe involved
• Pneumonia in Hospital Stay:
>50 years – 8.67 days
<50 years – 6.89 days
Significant p Value of about 0.002, in age distribution.
Mean duration of Hospital stay 6 – 8 days.
• Disease Outcome :
Discharged – 94%
Died – 6%
Significant p Value of about 0.016, in age distribution.
CONCLUSION o Males affected more than female o Streptococcal pneumonia is the common pathogen causing
community acquired pneumonia o Followed by Klebsiella pneumonia observed in this study. o E.coli, Pseudomonas ard staphylococcus observed in few patients. o Gram negative organism common in elderly patient, COPD and in
Smokers. o Common age group involved are 40 – 60 years. However old age
groups mostly affected in pneumonia. o Right lung is involved in majority of patients o Patients with comorbid conditions like Diabetes Mellitus are
affected by pneumonia o Smoking, COPD and Alcohol are major risk factors o Sputum culture yields organism o Blood culture yield no organism, In spite of pneumonia, sputum
culture is negative in some patients. o Significant morbidity and mortality in old age groups o Our study will use to identify the common organism in CMCH,
and useful for physicians to start empirical treatment.
BIBLIOGRAPHY
1. Garibaldi, R. A. (1985). Epidemiology of community-acquired
respiratory tract infections in adults. Incidence, etiology, and impact.
The American Journal of Medicine , 78 (6B), 32–37.
2. Macfarlane, J. T., Ward, M. J., Finch, R. G., & Macrae, A. D. (1982). HOSPITAL STUDY OF ADULT COMMUNITY - ACQUIRED PNEUMONIA. The Lancet , 320 (8292), 255–258. https://doi.org /10.1016/ S0140-6736 (82)90334-8 3. Black, A. D. (2016). Non-infectious mimics of community-acquired
pneumonia. Pneumonia, 8 (1), 2.doi:10.1186/s41479-016-0002-1
4. 4.Fauci (2012). Harrison's Principles of Internal Medicine (18 th
Edition). New York, USA: McGraw-Hill Professional Publishing .
Disorder of Respiratory System, Disease of Respiratory System.
Pneumonia. Chptr 257.
5. Gupta D, Aggarwal R, Aggarwal AN, et al. Pneumonia Guidelines
working Group. Guidelines for diagnosis and management of
community and hospital – acquired pneumonia in adults: Joint
ICS/NCCP(I) recommendations Indian J Chest Dis Allied Sci
2012:54:267-81
6. Barrett, K. E., Boitano, S., & Barman, S. M. (2010). Ganong’s Review
of Medical Physiology (21stEdition). New York, USA: McGraw-Hill
Professional Publishing. Retrieved from http://public.eblib.com
/choice/ publicfullrecord. aspx?p = 4657620
7. Fick RB (Jr), Reynolds HY. Changing spectrumof pneumonia: News
media creation or clinicalreality? Am J Med 1983; 74 : 1-8.
8. Behera D, Pneumonia. In: Munjal YP, Sharma SK, Ed.API Textbook
of Medicine. Ed10, New Delhi.Jaypee2015:2340.
9. Black, A. D. (2016). Non-infectious mimics of community-acquired
pneumonia. Pneumonia, 8 (1), 2.doi:10.1186/s41479-016-0002-1
10. Dhiman Ganguly. API Text Book of Medicine, Section 23,
Pneumonia, 9th edition, Chapter 7, 2012, p. 1719-1725.
11. Fauci (2012). Harrison's Principles of Internal Medicine (18 th
Edition). New York, USA: McGraw-Hill Professional Publishing .
Disorder of Respiratory System, Pneumonia.
12. Standring, S., & Gray, H. (Eds.). (2009). Gray’s anatomy: the
anatomical basis of clinical practice (40.ed., reprinted). Edinburgh:
Churchill Livingstone Elsevier
13. Chaurasia’s, B. D. (2004). Human anatomy: regional and applied
dissection and clinical . New Delhi,India: CBS Publishers &
Distributors
14. Abdullah BB, Zoheb M, Ashraf SM, Ali S, NausheenN. A Study of
Community-Acquired Pneumonias inElderly Individuals in Bijapur.
ISRN Pulmonology 2012; 936790. doi:10.5402/2012/936790
15. Bochud PY, Moser F, Erard P, Verdon F, Studer JP,Villard G, et al .
Community- acquired pneumonia. Aprospective outpatient study.
Medicine (Baltimore) 2001; 80(2):75–87.
16. Epidemiology of Community-Acquired Pneumonia Supplement to
Journal of the Association of Physicians of India. July 2013, Vol. 61
17. Macfarlane J. Community-acquired pneumonia. Br J Dis Chest, 1987;
81: 116.
18. Colloniz C, Ewig S, Polverino E, et al. Community – acquired
Pneumonia in outpatients: aetiology and outcomes. Eur Respir J
2012;40;931-8
19. Bhatty, M., Pruett, S. B., Swiatlo, E., & Nanduri, B. (2011). Alcohol
abuse and Streptococcuspneumoniae infections: Consideration of
Virulence Factors and Impaired ImmuneResponses. Alcohol
(Fayetteville, N.Y.), 45 (6), 523-539.
doi:10.1016/j.alcohol.2011.02.305.
20. Gupta D, Aggarwal R, Aggarwal AN, et al. Pneumonia Guidelines
working Group. Guidelines for diagnosis and management of
community and hospital – acquired pneumonia in adults: Joint
ICS/NCCP(I) recommendations. Lung India 2012:29:S27-62/
21. File, T. M. (2003). Community-acquired pneumonia. Lancet (London,
England) , 362 (9400), 1991–2001. https://doi.org/10.1016/S0140-
6736(03)15021-
22. Ewig, S., Ruiz, M., Mensa, J., Marcos, M. A., Martinez, J. A.,
Arancibia, F., … Torres, A. (1998). Severecommunity-acquired
pneumonia. Assessment of severity criteria. American Journal
ofRespiratory and Critical Care Medicine , 158 (4), 1102–
1108. https://doi.org/10.1164/ajrccm.158.4.9803114
23. Kasper, D. L., & Harrison, T. R. (2005). Harrison's principles of
internal medicine . New York: McGraw-Hill, Medical Pub. Division
24. 16. Barrett - Conner EB. The non value of sputum culture in the
diagnosis of pneumococcal pneumonia. Am Rev Respir Dis 1971 ; 103
25. . Fauci (2012). Harrison's Principles of Internal Medicine (18 th
Edition). New York, USA: McGraw-Hill Professional Publishing .
Disorder of Respiratory System, Pneumonia. Chptr 257.
26. Mandell, L. A., & Wunderink, R. (2012). Chapter 257. Pneumonia. In
D. L. Longo, A. S. Fauci, D. L.Kasper, S. L. Hauser, J. L. Jameson, &
J. Loscalzo (Eds.), Harrison’s Principles of InternalMedicine (18th
ed.). New York, NY:TheMc Graw Hill Companies. Retrieved from
access medicine.mhmedical.com/content.aspx?aid=9128129
27. Basi, S. K., Marrie, T. J., Huang, J. Q., & Majumdar, S. R. (2004).
Patients admitted to hospital withsuspected pneumonia and normal
chest radiographs: Epidemiology, microbiology, andoutcomes. The
American JournalofMedicine , 117 (5), 305311 .https:// doi.org
/10.1016 /j.amjmed.2004.03.029
28. .Fein AM, Feinsilver SH, Niedennan MS. Atypicalmanifestation of
pneumonia in the elderly. Clin ChestMed 1991; 12:319-36.
29. Dey AB, Nagarkar KM, Kumar V. Clinicalpresentation and predictors
of outcome in adultpatients with community-acquired pneumonia. Natl
Med J India 1997; 10 : 169-72.30. Metlay, J. P., Kapoor, W. N., &
Fine, M. J. (1997). Does this patient have community-
acquiredpneumonia? Diagnosing pneumonia by history and physical
examination. JAMA , 278 (17),1440–1445
30. Samuel KM. Notes on Clinical LaboratoryTechniques. 4th edn.
Madras: MGK Iyyer & Sons;1986 : 168.
31. Lionel A. Mandell , Richard Wunderink. Harrison s Principles of
Internal
32. Medicine, 18th edition, Pneumonia, Chapter 257, 2012, p. 2130-2141
33. Vilar, J., Domingo, M. L., Soto, C., & Cogollos, J. (2004). Radiology
of bacterial pneumonia. EuropeanJournal of Radiology , 51 (2), 102–
113. https: //doi. org /10.1016 /j.ejrad. 2004.03.010
34. Vilar J, Domingo ML, Soto C, Cogollos J. Radiology of bacterial
pneumonia.Eur J Radiol 2004;51:102-13
35. Madhu SV, Gupta U, Guleria JS, Talwar V.Clinical and
bacteriological profile ofhospitalized community acquired
pneumonias:A preliminary study. Indian J Chest Dis Allied Sci 1990;
32 : 95-100
36. Wollschlager C, Khan F. The contribution of blood culturesto the
diagnosis and management of community acquiredpneumonia. Am
Rev Resp Dis 1985 ; 131 : 80.
37. . Reimer, L. G., & Carroll, K. C. (1998). The role of the microbiology
laboratory in the diagnosis of lowerrespiratory tract infections.
Clinical Infectious Diseases: An Official Publication of theInfectious
Diseases Society of America , 26 (3), 742–748.
38. . Finch, R. G., & Woodhead, M. A. (1998). Practical considerations
andguidelines for the managementof community-acquired pneumonia.
Drugs , 55 (1), 31–45.
39. Shah BA, Ahmed W, Dhobi GN, Shah NN, KhursheedSQ, Haq I.
Validity of pneumonia severity index andCURB-65 severity scoring
systems in community acquired pneumonia in an Indian setting.
Indian JChest Dis Allied Sci 2010; 52(1): 9-17.
40. Shah BA, Ahmed W, Dhobi GN, et al. Validity of Pneumonia Severity
Index and CURB-65 severity scoring systems in Community acquired
pneumonia in an Indian setting. Indian J Chest Dis Allied Sci 2010;
52: 9-17.
41. . Oberoi A, Agarwal A. Bacteriological profile, Serology and
antibiotic Sensitivity pattern of microorganisms from community
acquired Pneumonia. JK Sci., 2006; 8: 79–82.
42. . Amsden GW. Pneumococcal macrolide resistance – Myth or reality?
J Antimicrob Chemother 1999;44:1-6.
43. Sharma BK, Manjunatha S, Varma S. Profile of pneumoniasin
hospitalized medical patients. Ind J Chest Dis Allied Sci 1988 ; 30 :
199-204.
44. MacFarlance J. Community acquired pneumonia. Br J Dis Chest
1987;81:116-45.
45. Barlett JG, Dowell SF, Mandell LA, et al. Practice guidelinesfor the
management of community - acquired pneumonia inadults. Clin Infect
Dis 2000 ; 31 : 347-82.
46. Fiberesima FP1, Onwuchekwa AC. Community acquired pneumonia
in Port Harcourt Rivers State of Nigeria. Cent Afr J Med., 2008; 54(1-
4): 1-8.
47. Meehan, T. P., Fine, M. J., Krumholz, H. M., & et al. (1997). The
quality of care, process, andoutcomes in elderly patients with
pneumonia. JAMA, 278 (23), 2080-2084.doi: 10.1001 /jama.
1997.03550230056037
48. Kulpati DD, Khastgir T. Reappraisal of pneumonias. J Assoc
Physicians India 1988;36:660-4.
49. Macfarlane J. An overview of community acquired pneumonia.
Semin Respir Infect., 1994; 9: 153
50. Seaton A, Seaton D., AG Leich. Crofton & Douglas’s. Respiratory
Diseases. 5th edition, Vol-1 Chapter 13, p. 356-429.
51. Bansal S, Kashyap S, Pal L.S, Goel A. Clinical andBacteriological
Profile of Community AcquiredPneumonia in Shimla, Himachal
Pradesh. Indian JChest Dis Allied Sci 2004; 46: 17-22.
ANNEXURE-1
PROFORMA
NAME AGE OCCUPATION SEX SOCIO ECONOMIC IP NO STATUS ADDRESS CHIEF COMPLAINTS
PRESENT HISTORY Yes/no Duration Other 1. COUGH features 2. FEVER 3. EXPECTORATION 4. DYSPNOEA 5. PLEURITIC CHEST PAIN 6. HEAMOPTYSIS 7. ALTERED SENSORIUM
PAST HISTORY Duration Treatment 1. SHT 2. DM 3. COPD 4. TB 5. EPILEPSY/CVA 6. HIV 7. CAD PERSONAL HISTORY 1. ALCOHOL Quantity - Duration CONSUMPTION- 2. SMOKING 3. DIET 4. DRUG INTAKE GENERAL EXAMINATION BP CONSCIOUS LEVEL-
PR PALLOR
SPO2 ICTERUS-
TEMP CYANOSIS
RR DYSPNEA-
PEDAL EDEMA- SYSTEM EXAMINATION – CVS RS ABD CNS BASE LINE CBC RFT LFT INVESTIGATIONS-
SPECIAL BLOOD SPUTUM SPUTU SPUTU BLOOD PLEURAL INVESTIGATIONS AFB M M CULTURE FLUID GRAM CULTU CULTURE STAIN RE
RADIOLOGICAL X RAY CHEST CT CHEST INVESTIGATIONS
FINAL DIAGNOSIS TREATMENT
ANNEXURE -2
CONSENT FORM
Yourself Mr./Mrs./Ms……………………………….. are being asked to be a participant in the research study titled “ Clinical, Bacteriological and
Radiological Study of Community Acquired Pneumonia ”in CMC Hospital,
Coimbatore, conducted by DR.R.REKA M.D., Post Graduate Student,
Department of General Medicine, Coimbatore Medical College. You are eligible after looking into the inclusion criteria. You can ask any question you may have before agreeing to participate.
Research Being Done
Clinical, Bacteriological and Radiological Study of Community Acquired Pneumonia Purpose of Research To study Clinical, Bacteriological and Radiological aspect of Community Acquired Pneumonia Decline from Participation
You have the option to decline from participation in the study existing protocol for your condition.
Privacy and Confidentiality
Privacy of individuals will be respected and any information about you or provided by you during the study will be kept strictly confidential.
Authorization to publish Results
Results of the study may be published for scientific purposes and/or
presented to scientific groups, however you will not be identified.
Statement of Consent
I volunteer and consent to participate in this study. I have read the
consent or it has been read to me. The study has been fully explained to
me, and I may ask questions at any time.
------Signature /Left thumb impression Date (volunteer)
------Signature of witness Date
ஒ த ப வ
ெபய :
வய>:
பாலின :
GகவZ :
ேகாைவ அர4 மK>வக QZ
மK>வமைனய* மK>வ ேரகா .ர தைலைமய*
நைடெபN இத ஆ வ* GTசமத>ட கல> ெகா ள
சமதிகிேற. இத ஆ வ* எைன ப றி வ*வரகைள
பா>காEட இத ஆ வ* ெவள+ய*டஆேசபைண இ ைல
எN ெதZவ*>ெகா கிேற. இத ஆ வ* இK> எத
ேநரதிP வ*லகிெகா R உZைம உ:எN அறிேவ.
இட :
ேததி :
ifbahg;gk; / nuif
ANNEXURE-3 MASTER CHART S.NO S.NO A/S COUGH FEVER EXPECToRATION CHESTPAIN PLEURITIC DYSPNOEA HEMOPTYSIS CREPITATIONS CYANOSIS BS BRONCHIAL SENSORIUM ALTERED EFFUSION PLEURAL SMOKING ALCOHOL DM/SHT COPD STAIN GRAM SPUTUM C/S SPUTUM C/S BLOOD FLUID ANALYSIS PLEURAL DATION CONSOLI DURATION
NAME OUTCOME CXR CHEST CT
RT 1 RAMAN 20/M P P P P A A P A P A A YES YES NO NO POS STREP NO NO RTLL 7 DISCHARGED LL RT 2 KARUPPUSAMY 45/M P P P A P A P A P A A YES NO DM NO POS STREP NO NO RTLL 6 DISCHARGED LL 3 KRISHNAN 50/M P P P P P A P A P A A YES NO NO YES POS STREP NO NO B/L B/L 9 DISCHARGED LT LT 4 SAGADEVAN 55/M P P P A A A P A P A A NO YES NO YES POS STREP NO NO 6 DISCHARGED LL LL DM/ 5 SIVASAMY 60/M P P A P P P P A P A A YES YES YES NEG KLEB NO NO NO B/L 9 DISCHARGED SHT LT LT 6 KANNAN 46/M P P P P P A P A P A A NO NO NO NO POS STAPH NO NO 6 DISCHARGED LL LL 7 ANBARASAN 52/M P P P P P A P A P A A YES YES DM YES NG NG NO NO B/L B/L 8 DISCHARGED LT LT 8 KITTAN 61/M P P P P P A P P P A A YES YES DM YES POS STAPH NO NO 9 DISCHARGED LL LL LT LT 9 KATHIRAVAN 35/M P P P P A A P A P A A NO NO NO NO POS STREP NO NO 8 DISCHARGED LL LL 10 JAYAPAL 56/M P P P P A A P A P A A NO YES SHT NO NEG KLEB NO NO LTUL B/L 8 DISCHARGED DM/ RT 11 GOPAL 58/M P P P A P A P A P A A YES YES NO POS STREP NO NO RTLL 7 DISCHARGED SHT LL RT 12 RAJENDRAN 60/M P P P P P A P A P A A YES NO DM YES POS STREP NO NO RTLL 8 DISCHARGED LL DM/ 13 RAJA 62/M P P P P P P P P P P A YES YES YES NEG PSEUD NO NO B/L B/L 14 DIED SHT
14 RANGASAMY 40/M P P P P P A P A P A A YES YES NO YES NO MIXED NO NO B/L B/L 6 DISCHARGED RT 15 RAMASAMY 58/M P P P P P A P A P A A YES YES NO NO POS STREP NO NO RTLL 6 DISCHARGED LL LT 16 RANJITH 35/M P P P P P A P A P A A NO NO NO NO POS STREP NO NO LTLL 7 DISCHARGED LL RT 17 RAMESH 32/M P P P P P A P A P A A NO YES NO NO POS STREP NO NO RTLL 6 DISCHARGED LL 18 CHELLAPAN 60/M P P P P P A P A P A A YES NO NO YES NEG KLEB NO NO LTUL B/L 8 DISCHARGED DM/ LT 19 PALANISAMY 56/M P P P P P P P A P A A YES YES NO POS STREP NO NO LTLL 6 DISCHARGED SHT LL 20 PERUMAL 62/M P P P P P P P P P A A YES YES DM YES NEG ESCHER NO NO B/L B/L 12 DISCHARGED RT 21 MUTHUSAMY 60/M P P P P P A P A P A A YES YES SHT YES POS STREP NO NO RTLL 7 DISCHARGED LL DM/ RT 22 MUNUSAMY 58/M P P P P P A P A P A A NO NO YES POS STREP NO NO RTLL 7 DISCHARGED SHT LL 23 KANNIAPPAN 46/M P P P P P P P A P A A YES YES NO NO POS STREP NO NO LTUL LTUL 7 DISCHARGED 24 SILAMBARASAN 33/M P P P A P A P A P A A NO NO NO NO NEG KLEB NO NO RTUL RTUL 8 DISCHARGED DM/ 25 MOHAN 62/M P P P P P A P P P A P YES YES YES NEG PSEUD NO STAPH B/L B/L 10 DISCHARGED SHT DM/ 26 MALAIASAMY 59/M P P P P P A P A P A A YES YES YES POS STAPH NO NO LTLL LTLL 8 DISCHARGED SHT 27 DURAISAMY 59/M P P P P P A P A P A A NO NO NO NO POS STREP NO NO RTLL RTLL 7 DISCHARGED DM/ 28 THIRUMALAI 68/M P P P P P A P P P P P YES YES YES POS STREP NO NG B/L B/L 13 DIED SHT 29 NEELAMEGAM 63/M P P P P P A P P P A A YES NO SHT YES NEG PSEUD NO NO LTLL B/L 10 DISCHARGED 30 NATESAN 66/M P P P P P P P A P A A NO NO DM NO NEG KLEB NO NO RTUL RTUL 7 DISCHARGED 31 NAGARAJ 56/M P P P P P P P A A A A YES YES NO NO POS STREP NO NO B/L B/L 6 DISCHARGED 32 NANJAPPAN 65/M P P P P P A P A P A A YES YES NO NO POS STREP NO NO LTLL LTLL 8 DISCHARGED 33 CHIDAMBARA 48/M P P P P P A P A P A A NO NO NO NO POS STREP NO NO RTLL RTLL 6 DISCHARGED 34 MYILSAMY 38/M P P P P P A P A P A A YES NO NO YES POS STREP NO NO NO RTLL 6 DISCHARGED 35 MARIMUTHU 63/M P P P P P A P P P A A YES YES DM YES NEG KLEB NO NO B/L B/L 8 DISCHARGED 36 NALLAKANNU 49/M P P P P P A P A P A A YES NO NO NO NG NG NO NO RTLL RTLL 6 DISCHARGED
DM/ 37 RANGASAMY 70/M P P P P P P P P P P A YES YES YES POS STREP NO NO B/L B/L 12 DIED SHT 38 JOTHI 36/F P P P A A A P A P A A NO NO NO NO POS STREP NO NO RTLL RTLL 8 DISCHARGED 39 SELVI 43/F P P P A A A P A P A A NO NO DM NO NG NG NO NO RTLL RTLL 6 DISCHARGED DM/ 40 MYLATHAL 62/F P P P P P A P A P A A YES NO YES POS STAPH STAPH NO B/L B/L 10 DISCHARGED SHT 41 RAJAMMAL 35/F P P P A P A P A P A A NO NO NO NO POS STREP NO NO LTLL LTLL 8 DISCHARGED 42 KANNAMMAL 62/F P P P P P A P A P A A NO NO SHT YES POS STREP NO NO LTLL LTLL 8 DISCHARGED 43 SEETHA 46/F P P P P A A P A P A A NO NO SHT NO POS STREP NO NO RTLL B/L 9 DISCHARGED 44 LAKSHMI 30/F P A P P P A A A A A A NO NO NO NO NG NG NO NO RTUL RTUL 6 DISCHARGED 45 PARVATHI 46/F P P P P P A P A P A A NO NO NO NO NEG KLEB NO NO LTUL LTUL 6 DISCHARGED 46 KARUPATHAL 59/F P P P P P A P A P A A NO NO DM NO POS STREP NO NO RTLL RTLL 7 DISCHARGED DM/ 47 CHELLAMMAL 61/F P P P P P A P A P A A NO NO YES POS STREP NO NO RTLL RTLL 8 DISCHARGED SHT DM/ 48 RANGAMMAL 62/F P P P P P A P A P A A NO NO YES POS STAPH NO NO B/L B/L 10 DISCHARGED SHT 49 RAJAMANI 70/F P P P P P A P A P A P YES NO NO YES POS STREP NO STREP RTUL RTUL 12 DISCHARGED 50 RAJAMMAL 60/F P P P P P A P A P A A NO NO SHT YES NO MIXED NO NO LTLL LTLL 10 DISCHARGED
ABBREVIATIONS FOR MASTER CHART
P - PRESENT
A - ABSENT
POS - POSITIVE
NEG - NEGATIVE
DM - DIABETES MELLITUS
SHT-SYSTEMIC HYPERTENSION
RT UL - RIGHT UPPER LOBE
RT LL - RIGHT LOWER LOBE
LT UL - LEFT UPPER LOBE
LT LL - LEFT LOWER LOBE
B/L - BILATERAL
C/S - CULTURE AND SENSITIVITY
CXR - CHEST X RAY
STREP - STREPTOCOCCUS PNEUMONIAE
STAPH - STAPH AUREUS
KLEB - KLEBSIELLA PNEUMONIAE
PSEUDO - PSEUDOMONAS AERUGINOSA
ESCHERIA - ESCHERIA COLI
NG - NO GROWTH